In accordance with our previous findings on p53 mutational analysis, to the current IHC results suggest that the p53 pathway is perhaps an early event and Wnt-pathway regulated changes in C-MYC are in the later phase of colitis associated carcinogenesis [38]. The gene discussed is TP53; the disease is colitis.